The transaction includes an initial payment of 176 million euros, or approximately $204 million, slated for completion by the end of this year. An additional 35 million euros remains tied to contingent milestone performance. Management intends to leverage a combination of existing cash reserves and revolving credit facilities to finalize the purchase.

By folding eCential’s specialized robotics into the Astra ecosystem, Enovis seeks to build a more cohesive technological footprint. The company anticipates that this integration will drive better patient outcomes while reducing the operational friction currently faced by surgical teams.